perinatologyРоссийский вестник перинатологии и педиатрииRossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)1027-40652500-2228Ltd. “The National Academy of Pediatric Science and Innovation”10.21508/1027-4065-2022-67-6-40-45perinatology-1740Research ArticleОБЗОРЫ ЛИТЕРАТУРЫLITERATURE REVIEWSГиперлипидемии у детей: нерешенные проблемыHyperlipidemia in children: Unsolved problemshttps://orcid.org/0000-0002-5723-3687НикитинаМ. И.NikitinaM. I.

Никитина Майя Игоревна - ординатор кафедры факультетской педиатрии

443099 Самара, ул. Чапаевская, д. 89

Samara

doctor.nikitina@inbox.ruhttps://orcid.org/0000-0002-6078-2361СанталоваГ. В.SantalovaG. V.

Санталова Галина Владимировна - д.м.н. проф., зав. кафедрой факультетской педиатрии

443099 Самара, ул. Чапаевская, д. 89

Samara

ФГБОУ ВО «Самарский государственный медицинский университет» Минздрава РоссииРоссияSamara State Medical UniversityRussian Federation2022070120236764045Copyright © Ltd. “The National Academy of Pediatric Science and Innovation”, 20232023Ltd. “The National Academy of Pediatric Science and Innovation”Ltd. “The National Academy of Pediatric Science and Innovation”https://www.ped-perinatology.ru/jour/about/submissions#copyrightNoticehttps://www.ped-perinatology.ru/jour/article/view/1740

В статье представлены данные литературы по распространенности, диагностике и лечению гиперлипидемии, в том числе семейной гиперхолестеринемии у детей. Отмечено, что продолжается рост числа больных с гиперлипидемией во всем мире. Попрежнему гиперлипидемии рассматриваются факторами риска развития сердечно-сосудистых заболеваний и причиной высокой смертности в разных странах мира. Обращено внимание на возможность атеросклеротического поражения сосудов сердца у молодых людей и подростков. Отмечены заболевания у детей (сахарный диабет, ожирение, гипотиреоз, патология почек и др.), при наличии которых необходимо проводить диагностику гиперлипидемии. Нет четких рекомендаций для педиатров в отношении скрининга в целях выявления высокого уровня холестерина и сроков начала терапии.

The article presents literature review findings on the prevalence, diagnosis, and treatment of hyperlipidemia, including familial hypercholesterolemia in children. It is noted that the number of patients with hyperlipidemia continues to grow throughout the world. As before, hyperlipidemias are considered risk factors for the development of cardiovascular diseases and the cause of high mortality in different countries of the world. Attention is drawn to the possibility of atherosclerotic lesions of the heart vessels in young people and adolescents. Diseases in children (diabetes mellitus, obesity, hypothyroidism, renal pathology, etc.) have been noted, which necessitate diagnosing hyperlipidemia. There are no clear guidelines for pediatricians regarding cholesterol screening and timing of therapy initiation.

детигиперхолестеринемиялипопротеиды низкой плотностидиагностикаскринингсердечно-сосудистые заболеванияchildrenhypercholesterolemialow density lipoproteinsdiagnosticsscreeningcardiovascular diseasesReferencesCatapano A.L., Graham I., De Backer G., Wiklund O., Chapman M.J., Drexel H., et al; ESC Scientific Document Group. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J 2016; 37(39): 2999–3058. DOI: 10.1093/eurheartj/ehw272Catapano A.L., Graham I., De Backer G., Wiklund O., Chapman M.J., Drexel H., et al; ESC Scientific Document Group. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J 2016; 37(39): 2999–3058. DOI: 10.1093/eurheartj/ehw272Mărginean C.O., Melit L.E., Dobreanu M., Mărginean M.O. Type V hypertriglyceridemia in children, a therapeutic challenge in pediatrics: A case report and a review of the literature. Medicine 2017; 96(51): e8864. DOI: 10.1097/md.0000000000008864Mărginean C.O., Melit L.E., Dobreanu M., Mărginean M.O. Type V hypertriglyceridemia in children, a therapeutic challenge in pediatrics: A case report and a review of the literature. Medicine 2017; 96(51): e8864. DOI: 10.1097/md.0000000000008864Ramaswamia U., Humphriesb S. E., Priestley-Barnhamc L., Greend P., Walde D.S., Cappsf N. Current management of children and young people with heterozygous familial hypercholesterolaemia — HEART UK statement of care. Atherosclerosis 2019; 290: 1–8. DOI: 10.1016/j.atherosclerosis.2019.09.005Ramaswamia U., Humphriesb S. E., Priestley-Barnhamc L., Greend P., Walde D.S., Cappsf N. Current management of children and young people with heterozygous familial hypercholesterolaemia — HEART UK statement of care. Atherosclerosis 2019; 290: 1–8. DOI: 10.1016/j.atherosclerosis.2019.09.005Collins R., Reith C., Emberson J., Armitage J., Baigent C., Blackwell L. et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet 2016; 388: 2532–2561. DOI: 10.1016/S0140–6736(16)31357–5Collins R., Reith C., Emberson J., Armitage J., Baigent C., Blackwell L. et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet 2016; 388: 2532–2561. DOI: 10.1016/S0140–6736(16)31357–5Watts G.F., Gidding S., Wierzbicki A.S., Toth P.P., Alonso R., Brown W.V. et al. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation. Int J Cardiol 2014; 171(3): 309–325. DOI: 10.1016/j.Ùcard.2013.11.025Watts G.F., Gidding S., Wierzbicki A.S., Toth P.P., Alonso R., Brown W.V. et al. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation. Int J Cardiol 2014; 171(3): 309–325. DOI: 10.1016/j.Ùcard.2013.11.025Goldberg A., Hopkins P., Toth P., Ballantyne C., Robinson J., Daniels S. et al. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol 2011; 5: 133–140. DOI: 10.1016/j.jacl.2011.04.003Goldberg A., Hopkins P., Toth P., Ballantyne C., Robinson J., Daniels S. et al. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol 2011; 5: 133–140. DOI: 10.1016/j.jacl.2011.04.003Ежов М.В., Сергиенко И.В., Рожкова Т.А., Кухарчук В. В., Коновалов Г. А., Мешков А. Н. и др. Российские рекомендации по диагностике и лечению семейной гиперхолестеринемии. Атеросклероз и дислипидемии 2016; 25(4): 21–29.Ezhov M.V., Sergienko I.V., Rozhkova T.A., Kukharchuk V.V., Konovalov G.A., Meshkov A.N. et al.The Russian references on diagnostics and treatment of a family hypercholesterolaemia. Ateroskleroz i dislipidemii 2016; 25(4): 21–29. (in Russ.)European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z., Catapano A.L., De Backer G., Graham I., Taskinen M.R., Wiklund O. et al.; ESC Committee for Practice Guidelines (CPG) 2008–2010 and 2010–2012 Committees. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011; 32(14): 1769–818. DOI: 10.1093/eurheartj/ehr158European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z., Catapano A.L., De Backer G., Graham I., Taskinen M.R., Wiklund O. et al.; ESC Committee for Practice Guidelines (CPG) 2008–2010 and 2010–2012 Committees. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011; 32(14): 1769–818. DOI: 10.1093/eurheartj/ehr158Coakley J.C. Lipids in Children and Links to Adult Vascular Disease. Clin Biochem Rev 2018; 39(3): 65–76Coakley J.C. Lipids in Children and Links to Adult Vascular Disease. Clin Biochem Rev 2018; 39(3): 65–76Ежов М.В., Бажан С.С., Ершова А.И., Мешков А.Н., Соколов А.А., Кухарчук В.В. и др. Клинические рекомендации по семейной гиперхолестеринемиии. Атеросклероз и дислипидемии 2019; 34(1): 5–43.Ezhov M.V., Bazhan S.S., Yershova A.I., Meshkov A.N., Sokolov A.A., Kukharchuk V.V. et al. Clinical recommendations for familial hypercholesterolemia. Ateroskleroz i dislipidemii 2019; 34: 5–43. (in Russ.)Ference B., GinsbergH., Graham I., Ray K., Packard C., Bruckert E. et al. Low-density lipoproteins cause atheroscle-rotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 2017; 38(32): 2459–2472. DOI: 10.1093/eurheartj/ehx144Ference B., GinsbergH., Graham I., Ray K., Packard C., Bruckert E. et al. Low-density lipoproteins cause atheroscle-rotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 2017; 38(32): 2459–2472. DOI: 10.1093/eurheartj/ehx144Рубаненко О.А., Кириченко Н.А., Фатенков О.В. Коррекция нарушений липидного обмена и системы гемостаза у пациентов высокого риска смерти от сердечно-сосудистых заболеваний. Наука и инновации в медицине 2016; 1(1): 41–45.Rubanenko O.A., Kirichenko N.A., Fatenkov O.V. Correction of lipid and hemostatic disorders in patients at high risk of cardiovascular death. Scie Innovat Med 2016; 1(1): 41–45. (in Russ.) DOI: 10.35693/2500–1388–2016–0–1–41–45Wiegman A., Gidding S., Watts G., Chapman M., Ginsberg H., Cuchel M. et al. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing. Eur Heart J 2015; 36: 2425–2437. DOI: 10.1093/eurheartj/ehv157Wiegman A., Gidding S., Watts G., Chapman M., Ginsberg H., Cuchel M. et al. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing. Eur Heart J 2015; 36: 2425–2437. DOI: 10.1093/eurheartj/ehv157Harada-Shiba M., Ohta T., Ohtake A., Ogura M., Dobashi K., Nohara A. et al.; Joint Working Group by Japan Pediatric Society and Japan Atherosclerosis Society for Making Guidance of Pediatric Familial Hypercholesterolemia. Guidance for Pediatric Familial Hypercholesterolemia 2017. J Atheroscler Thromb 2018; 25(6): 539–553. DOI: 10.5551/jat.CR002Harada-Shiba M., Ohta T., Ohtake A., Ogura M., Dobashi K., Nohara A. et al.; Joint Working Group by Japan Pediatric Society and Japan Atherosclerosis Society for Making Guidance of Pediatric Familial Hypercholesterolemia. Guidance for Pediatric Familial Hypercholesterolemia 2017. J Atheroscler Thromb 2018; 25(6): 539–553. DOI: 10.5551/jat.CR002Stempel H., Dodge A., Marriott E., Peterson A.L. Referral Patterns and Cascade Screening for Familial Hypercholesterolemia in a Pediatric Lipid Clinic. J Pediatr 2016; 178: 285–287. DOI: 10.1016/j.jpeds.2016.08.016Stempel H., Dodge A., Marriott E., Peterson A.L. Referral Patterns and Cascade Screening for Familial Hypercholesterolemia in a Pediatric Lipid Clinic. J Pediatr 2016; 178: 285–287. DOI: 10.1016/j.jpeds.2016.08.016Nordestgaard B.G., Chapman M.J., Humphries S.E., Ginsberg H.N., Masana L., Descamps O.S. et al.; European Atherosclerosis Society Consensus Panel. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J 2013; 34(45): 3478–90a. DOI: 10.1093/eurheartj/eht273Nordestgaard B.G., Chapman M.J., Humphries S.E., Ginsberg H.N., Masana L., Descamps O.S. et al.; European Atherosclerosis Society Consensus Panel. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J 2013; 34(45): 3478–90a. DOI: 10.1093/eurheartj/eht273Fredrickson D.S., Lees R.S. A system for phenotyping hyperlipoproteinemia. Circulation 1965; 31: 321–327. DOI: 10.1161/01.cir.31.3.321Fredrickson D.S., Lees R.S. A system for phenotyping hyperlipoproteinemia. Circulation 1965; 31: 321–327. DOI: 10.1161/01.cir.31.3.321Justo R.N. Management of familial hypercholesterolaemia in children and adolescents. J Paediatr Child Health 2012; 48(2): E53–58. DOI: 10.1111/j.1440–1754.2011.02206. xJusto R.N. Management of familial hypercholesterolaemia in children and adolescents. J Paediatr Child Health 2012; 48(2): E53–58. DOI: 10.1111/j.1440–1754.2011.02206. xЕршова А.И., Аль Раши Д.О., Иванова А.А., Аксенова Ю.О., Мешков А.Н. Вторичные гиперлипидемии: этиология и патогенез. Российский кардиологический журнал 2019; 5: 74–81.Ershova A.I., Al Rashi D.O., Ivanova A.A., Aksenova Yu.O., Meshkov A.N. Secondary hyperlipidemias: etiology and pathogenesis. Rossiiskii kardiologicheskii zhurnal 2019; 5:74–81. (in Russ.)Туркина Т.И., Щербакова М.Ю. Особенности дислипидемий у детей. Рациональная фармакотерапия в кардиологии 2011; 7(1): 65–69.Turkinа T.I., Shcherbakova M.Yu. Dyslipidemia features in children. Ratsional’naya farmakoterapiya v kardiologii 2011; 7(1): 65–69. (in Russ.) DOI: 10.20996/1819–6446–2011–7–1–65–69Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 2011; 128 Suppl 5(Suppl 5): S213–56. DOI: 10.1542/peds.2009–2107CExpert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 2011; 128 Suppl 5(Suppl 5): S213–56. DOI: 10.1542/peds.2009–2107CDeSantes K., Dodge A., Eickhoff J., Peterson A.L. Improving Universal Pediatric Lipid Screening. J Pediatr 2017; 188: 87–90. DOI: 10.1016/j.jpeds.2017.05.030DeSantes K., Dodge A., Eickhoff J., Peterson A.L. Improving Universal Pediatric Lipid Screening. J Pediatr 2017; 188: 87–90. DOI: 10.1016/j.jpeds.2017.05.030Сусеков А.В., Яфарова А.А., Щербакова М.Ю., Мешков А.Н. Регрессия ксантоматоза у 12-летнего пациента с гомозиготной формой семейной гиперхолестеринемии: клинический случай. Consilium Medicum. Педиатрия 2016; 3: 103–108.Susekov A.V., Jafarov A.A., Scherbakova M.Yu., Meshkov A.N. Regression of a xanthomatosis at the 12-year-old patient with a homozygous form of a family hypercholesterolaemia: clinical case. Consilium Medicum. Pediatriya 2016; 3: 103–108. (in Russ.)Kusters D.M., de Beaufort C., Widhalm K., Guardamagna O., Bratina N., Ose L., Wiegman A. Paediatric screening for hypercholesterolaemia in Europe. Arch Dis Child 2012; 97(3): 272–276. DOI:10.1136/archdischild-2011–300081Kusters D.M., de Beaufort C., Widhalm K., Guardamagna O., Bratina N., Ose L., Wiegman A. Paediatric screening for hypercholesterolaemia in Europe. Arch Dis Child 2012; 97(3): 272–276. DOI:10.1136/archdischild-2011–300081Wald D.S., Bestwick J.P., Morris J.K., Whyte K., Jenkins L., Wald N.J. Child-Parent Familial Hypercholesterolemia Screening in Primary Care. N Engl J Med 2016; 375(17): 1628–1637. DOI: 10.1056/NEJMoa1602777Wald D.S., Bestwick J.P., Morris J.K., Whyte K., Jenkins L., Wald N.J. Child-Parent Familial Hypercholesterolemia Screening in Primary Care. N Engl J Med 2016; 375(17): 1628–1637. DOI: 10.1056/NEJMoa1602777D’Innocenzo S., Biagi C., Lanari M. Obesity and the Mediterranean Diet: A Review of Evidence of the Role and Sustainability of the Mediterranean Diet. Nutrients 2019; 11(6): 1306. DOI: 10.3390/nu11061306D’Innocenzo S., Biagi C., Lanari M. Obesity and the Mediterranean Diet: A Review of Evidence of the Role and Sustainability of the Mediterranean Diet. Nutrients 2019; 11(6): 1306. DOI: 10.3390/nu11061306Farajian P., Risvas G., Karasouli K., Pounis G.D., Kastorini C.M., Panagiotakos D.B., Zampelas A. Very high childhood obesity prevalence and low adherence rates to the Mediterranean diet in Greek children: the GRECO study. Atheroscle-rosis 2011; 217(2): 525–530. DOI: 10.1016/j.atherosclero-sis.2011.04.003Farajian P., Risvas G., Karasouli K., Pounis G.D., Kastorini C.M., Panagiotakos D.B., Zampelas A. Very high childhood obesity prevalence and low adherence rates to the Mediterra-nean diet in Greek children: the GRECO study. Atherosclerosis 2011; 217(2): 525–530. DOI: 10.1016/j.atherosclerosis.2011.04.003Беляева Л.Е. Способно ли регулярное потребление «функциональной пищи» замедлить скорость атероге-неза? Вестник Витебского государственного медицин-ского университета 2012; 11(3): 15–27.Belyaeva L.E. Can regular consumption of «functional food» slow down the rate of atherogenesis? Vestnik Vitebskogo gosudarstvennogo medicinskogo universiteta 2012; 11(3): 15–27. (in Russ.)Василенко В.С., Семенова Е.С., Семенова Ю.Б. Липиды крови у спортсменов в зависимости от направленности тренировочного процесса. Педиатр 2017; 8(2): 10–14.Vasilenko V.S., Semenova E.S., Semenova Yu.B. Blood lipids in athletes depending on the orientation of the training process. Pediatr 2017; 8(2): 10–14. (in Russ.) DOI: 10.17816/PED8210–14Даутова А.З., Шамратова В.Г. Уровень липидов в кро-ви мужчин-спортсменов в зависимости от спортивной специализации. Наука и спорт: современные тенденции 2021; 9(3): 6–14.Dautova A.Z., Shamratova V.G. The level of lipids in the blood of male athletes depending on sports specialization. Nauka i sport: sovremennye tendencii 2021; 9(3): 6–14. (in Russ.)Пизова Н.В., Дружинин Д.С. Атеросклеротическое пора-жение сонных артерий у пациентов молодого возраста. Клиницист 2014; 8(1): 28–33.Pizova N.V., Druzhinin D.S. Сarotid atherosclerotic lesion in young patients. Klinirtsist 2014; 8(1): 28–33. (in Russ.) DOI: 10.17650/1818–8338–2014–1–28–33Петеркова В.А., Васюкова О.В. К вопросу о новой классификации ожирения у детей и подростков. Проблемы эндокринологии 2015; 61(2): 39–44.Peterkova V.A., Vasyukova O.V. About the new classification of obesity in the children and adolescents. Problemy endokrinologii 2015; 61(2): 39–44. (in Russ.) DOI: 10.14341/probl201561239–44Кухарчук В.В., Ежов М.В., Сергиенко И.В., Арабидзе Г.Г., Балахонова Т.В., Гуревич В.С. и др. Клинические рекомендации евразийской ассоциации кардиологов (ЕАК)/Национального общества по изучению атеросклероза (НОА, Россия) по диагностике и коррекции нарушений липидного обмена с целью профилактики и лечения атеросклероза (2020). Евразийский кардиологический журнал 2020; 2: 6–29.Kukharchuk V.V., Ezhov M.V., Sergienko I.V., Arabidze G.G., Balakhonova T.V., Gurevich V.S. et al. Eurasian association of cardiology (EAC)/Russian national atherosclerosis society (RNAS, RUSSIA) Guidelines for the diagnosis and correction of dyslipidemia for the prevention and treatment of atherosclerosis (2020). Evraziiskii kardiologicheskii zhurnal 2020; 2: 6–29. (in Russ.) DOI: 10.38109/2225–1685–2020–2–6–29]Shah A.S., Wilson D.P. Primary hypertriglyceridemia in children and adolescents. J Clin Lipidol 2015; 9(5 Suppl): S20–28. DOI: 10.1016/j.jacl.2015.04.004Shah A.S., Wilson D.P. Primary hypertriglyceridemia in children and adolescents. J Clin Lipidol 2015; 9(5 Suppl): S20–28. DOI: 10.1016/j.jacl.2015.04.004Valaiyapathi B., Ashraf A.P. Hospital Management of Severe Hypertriglyceridemia in Children. Curr Pediatr Rev 2017; 13(4): 225–231. DOI: 10.2174/1573400514666180117092707Valaiyapathi B., Ashraf A.P. Hospital Management of Severe Hypertriglyceridemia in Children. Curr Pediatr Rev 2017; 13(4): 225–231. DOI: 10.2174/1573400514666180117092707European Association for Cardiovascular Prevention & Rehabilitation; Reiner Z., Catapano A.L., De Backer G., Graham I., Taskinen M.R., Wiklund O. et al.; ESC Committee for Practice Guidelines (CPG) 2008–2010 and 2010–2012 Committees. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011; 32(14): 1769–1818. DOI: 10.1093/eurheartj/ehr158European Association for Cardiovascular Prevention & Rehabilitation; Reiner Z., Catapano A.L., De Backer G., Graham I., Taskinen M.R., Wiklund O. et al.; ESC Committee for Practice Guidelines (CPG) 2008–2010 and 2010–2012 Committees. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011; 32(14): 1769–1818. DOI: 10.1093/eurheartj/ehr158Петеркова В.А., Васюкова О.В. К вопросу о новой классификации ожирения у детей и подростков. Проблемы эндокринологии 2015; 61(2): 39–44.Peterkova V.A., Vasyukova O.V. About the new classification of obesity in the children and adolescents. Problemy endokrinologii 2015; 61(2): 39–44. (in Russ.) DOI: 10.14341/probl201561239–44

The authors declare that there are no conflicts of interest present.